Certain substances on the Domestic Substances List used primarily as pharmaceuticals
CAS RN | Common Pharmaceutical Name | Canada Gazette Notice | Final Screening Assessment | Conclusion on Section 64 criteria |
---|---|---|---|---|
50-06-6 | Phenobarbital | HTML | HTML | Does not meet |
50-18-0 | Cyclophosphamide | |||
55-86-7 | Mechlorethamine | |||
55-98-1 | Busulfan | |||
56-75-7 | Chloramphenicol | |||
57-41-0 | Phenytoin | |||
68-22-4 | Norethindrone | |||
71-58-9 | Medroxyprogesterone | |||
81-81-2 | Warfarin | |||
126-07-8 | Griseofulvin | |||
148-82-3 | Melphalan | |||
154-93-8 | Carmustine | |||
305-03-3 | Chlorambucil | |||
443-48-1 | Metronidazole | |||
446-86-6 | Azathioprine | |||
604-75-1 | Oxazepam | |||
7481-89-2 | Zalcitabine | |||
13010-47-4 | Lomustine | |||
18883-66-4 | Streptozocin | |||
20830-81-3 | Daunorubicin | |||
29767-20-2 | Teniposide | |||
30516-87-1 | Zidovudine | |||
51264-14-3 | Amsacrine | |||
10540-29-1 | Tamoxifen | HTML | HTML | |
23214-92-8 | Doxorubicin | HTML | HTML | |
33419-42-0 | Etoposide | HTML | HTML | |
59865-13-3 | Cyclosporin A | HTML | HTML | |
63798-73-2 | Cyclosporin E |
Date | Substances Affected | Activity |
---|---|---|
February 21, 2015 | All 28 substances | Publication of the final screening assessments in the Canada Gazette Part I: Vol. 149, No. 8 - February 21, 2015. |
March 22, 2014 | All 28 substances | Publication of the draft screening assessments in the Canada Gazette, Part I: Vol. 148, No. 12 - March 22, 2014 and start of 60-day public comment period, ending May 21, 2014. |
Background
The substances were flagged during the categorization process as high hazard by Health Canada based on classifications for carcinogenicity or developmental toxicity, and/or as priorities by Environment Canada based on concerns regarding persistence, bioaccumulation and inherent toxicity to non-human organisms.
If you have questions or comments, please contact us. Indicate on the envelope or subject line "Certain Substances on the Domestic Substances List Used Primarily as Pharmaceuticals".
Report a problem or mistake on this page
- Date modified: